Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$31.15 - $33.39 $475,037 - $509,197
-15,250 Reduced 6.82%
208,265 $6.92 Million
Q3 2022

Nov 10, 2022

BUY
$30.9 - $33.55 $4.31 Million - $4.68 Million
139,515 Added 166.09%
223,515 $7.05 Million
Q2 2021

Aug 13, 2021

BUY
$18.01 - $28.32 $18,010 - $28,320
1,000 Added 1.2%
84,000 $1.86 Million
Q1 2021

May 14, 2021

BUY
$19.76 - $29.89 $19,760 - $29,890
1,000 Added 1.22%
83,000 $2.18 Million
Q4 2020

Feb 05, 2021

SELL
$15.73 - $21.66 $133,705 - $184,110
-8,500 Reduced 9.39%
82,000 $1.53 Million
Q3 2020

Nov 06, 2020

SELL
$13.54 - $26.41 $135,400 - $264,100
-10,000 Reduced 9.95%
90,500 $1.54 Million
Q2 2020

Aug 13, 2020

SELL
$7.84 - $23.29 $117,600 - $349,350
-15,000 Reduced 12.99%
100,500 $2.34 Million
Q1 2020

May 14, 2020

SELL
$5.57 - $11.5 $5,570 - $11,500
-1,000 Reduced 0.86%
115,500 $970,000
Q4 2019

Feb 14, 2020

BUY
$7.9 - $10.14 $158,000 - $202,800
20,000 Added 20.73%
116,500 $1.14 Million
Q3 2019

Nov 01, 2019

SELL
$9.17 - $12.01 $265,930 - $348,290
-29,000 Reduced 23.11%
96,500 $916,000
Q2 2019

Aug 02, 2019

SELL
$10.88 - $17.6 $473,280 - $765,600
-43,500 Reduced 25.74%
125,500 $1.49 Million
Q1 2019

May 02, 2019

SELL
$15.51 - $17.61 $232,650 - $264,150
-15,000 Reduced 8.15%
169,000 $2.98 Million
Q4 2018

Jan 30, 2019

SELL
$14.52 - $19.72 $116,160 - $157,760
-8,000 Reduced 4.17%
184,000 $3.19 Million
Q3 2018

Nov 02, 2018

SELL
$14.85 - $16.35 $59,400 - $65,400
-4,000 Reduced 2.04%
192,000 $2.86 Million
Q2 2018

Aug 10, 2018

SELL
$13.8 - $16.8 $110,400 - $134,400
-8,000 Reduced 3.92%
196,000 $3.12 Million
Q1 2018

May 09, 2018

SELL
$13.8 - $16.2 $55,200 - $64,800
-4,000 Reduced 1.92%
204,000 $2.9 Million
Q4 2017

Feb 02, 2018

BUY
$13.55 - $15.8 $54,200 - $63,200
4,000 Added 1.96%
208,000 $2.91 Million
Q3 2017

Nov 01, 2017

BUY
$13.45 - $14.35 $2.74 Million - $2.93 Million
204,000
204,000 $2.92 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.